Genmab Future Growth

Future criteria checks 4/6

Genmab is forecast to grow earnings and revenue by 23.5% and 14.3% per annum respectively. EPS is expected to grow by 21.8% per annum. Return on equity is forecast to be 15.9% in 3 years.

Key information

23.5%

Earnings growth rate

21.8%

EPS growth rate

Biotechs earnings growth39.3%
Revenue growth rate14.3%
Future return on equity15.9%
Analyst coverage

Good

Last updated08 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:GE9 - Analysts future estimates and past financials data (DKK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202628,8527,9767,8198,29317
12/31/202524,6296,3355,9356,97523
12/31/202421,2745,5225,0845,91119
9/30/202419,8444,7026,5616,731N/A
6/30/202419,0165,5406,5156,735N/A
3/31/202417,7835,4675,3585,658N/A
12/31/202316,4744,3527,0047,380N/A
9/30/202316,8524,1635,6876,106N/A
6/30/202316,2274,6415,6346,037N/A
3/31/202315,2205,1976,1966,560N/A
12/31/202214,5055,4523,5953,912N/A
9/30/202211,9875,6543,4803,755N/A
6/30/202210,2103,9621,9642,234N/A
3/31/20229,0202,3771,3491,630N/A
12/31/20218,4172,9571,9762,228N/A
9/30/20217,9072,8739471,189N/A
6/30/20217,3212,5135,6095,820N/A
3/31/202110,8005,5855,4275,704N/A
12/31/202010,1114,7586,1266,433N/A
9/30/202011,0285,6497,1287,406N/A
6/30/202010,3445,6562,3692,647N/A
3/31/20205,6672,3632,4442,592N/A
12/31/20195,3662,1661,2151,326N/A
9/30/20193,6411,5281,2521,355N/A
6/30/20193,1991,1707821,248N/A
3/31/20192,9351,3457291,199N/A
12/31/20183,0251,4725371,015N/A
9/30/20182,8071,4245831,062N/A
6/30/20182,5321,239N/A892N/A
3/31/20182,7961,286N/A1,301N/A
12/31/20172,3651,104N/A1,589N/A
9/30/20172,2751,159N/A1,260N/A
6/30/20172,3161,354N/A1,422N/A
3/31/20171,8971,215N/A1,088N/A
12/31/20161,8161,187N/A328N/A
9/30/20161,463735N/A658N/A
6/30/20161,376686N/A591N/A
3/31/20161,196535N/A358N/A
12/31/20151,133764N/A311N/A
9/30/2015774443N/A70N/A
6/30/2015768463N/A23N/A
3/31/2015710420N/A98N/A
12/31/2014850301N/A133N/A
9/30/2014851292N/A110N/A
6/30/2014729138N/A-31N/A
3/31/2014751138N/A-108N/A
12/31/201366470N/A-128N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GE9's forecast earnings growth (23.5% per year) is above the savings rate (1%).

Earnings vs Market: GE9's earnings (23.5% per year) are forecast to grow faster than the German market (20.5% per year).

High Growth Earnings: GE9's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GE9's revenue (14.3% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: GE9's revenue (14.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GE9's Return on Equity is forecast to be low in 3 years time (15.9%).


Discover growth companies